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The process of myelination in the nervous system requires a coordinated formation of
both transient and stable supramolecular complexes. Myelin-specific proteins play key
roles in these assemblies, which may link membranes to each other or connect the
myelinating cell cytoskeleton to the extracellular matrix. The myelin protein periaxin is
known to play an important role in linking the Schwann cell cytoskeleton to the basal
lamina through membrane receptors, such as the dystroglycan complex. Mutations
that truncate periaxin from the C terminus cause demyelinating peripheral neuropathy,
Charcot-Marie-Tooth (CMT) disease type 4F, indicating a function for the periaxin
C-terminal region in myelination. We identified the cytoplasmic domain of β4 integrin
as a specific high-affinity binding partner for periaxin. The C-terminal region of periaxin
remains unfolded and flexible when bound to the third fibronectin type III domain of
β4 integrin. Our data suggest that periaxin is able to link the Schwann cell cytoplasm
to the basal lamina through a two-pronged interaction via different membrane protein
complexes, which bind close to the N and C terminus of this elongated, flexible molecule.
Keywords: myelin, Charcot-Marie-Tooth disease, periaxin, integrin, protein structural & functional analysis
INTRODUCTION
Long axonal segments in the vertebrate peripheral nervous system (PNS) are ensheathed by myelin,
which accelerates nerve impulse propagation and supports axons bothmechanically and trophically
(Nave, 2010). A Schwann cell wraps its plasma membrane, partially excluding its cytosol, several
times around a selected axonal process. This results in compact myelin, which has high lipid
and protein content and is responsible for axonal insulation. Compact myelin is surrounded
by a narrow compartment with higher cytosolic content, non-compact myelin, which acts as a
supportive metabolic compartment to ensure long-term myelin stability (Hartline, 2008). Both
myelin compartments contain a specific selection of proteins that have distinct tasks in ensuring the
correct formation and stability ofmyelin; failuremay result in one of several disease states, including
the peripheral inherited neuropathies Charcot-Marie-Tooth (CMT) disease and Dejerine-Sottas
syndrome (DSS). A large number of mutations in different PNS proteins has been linked to these
conditions (Boerkoel et al., 2002; DiVincenzo et al., 2014). However, only a handful of CMT
mutations have been characterized at the molecular structural level in order to understand the fine
details of disease mechanisms (Sakakura et al., 2011; Mittendorf et al., 2014; Ruskamo et al., 2017).
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The formation of myelin in the central nervous system
(CNS) and PNS, as well as its lifelong maintenance, requires an
intricate network of molecular interactions that link the myelin
membrane, the cytoskeleton of the myelinating glial cell, and the
extracellular matrix or the axonal surface together into a large
supramolecular complex. A number of proteins, many of which
seem specific for myelinating cells, have been pinpointed as
playing roles inmyelination; however, often themolecular details
of the relevant processes and protein-protein interactions remain
unknown. Myelin proteins have been specifically highlighted
as a knowledge gap in structural biology in the past (Xie
and Bourne, 2005), although more structural data from myelin
proteins are becoming available. However, structures of protein-
protein complexes of myelin-specific proteins mainly remain
uncharacterized to date.
Unlike oligodendrocytic myelin in the CNS, Schwann
cells in the PNS are surrounded by a carbohydrate-rich
basal lamina, which is adhered to the outermost (abaxonal)
Schwann cell plasma membrane bilayer via dystroglycans
and α6β4 integrin, contributing to the mechanical stability
of myelinated nerves (Einheber et al., 1993; Masaki et al.,
2002; Nodari et al., 2008). Additionally, non-compact PNS
myelin contains tight membrane-apposed structures at the
abaxonal layer. These structures surround cytosolic channels of
non-compact myelin, referred to as Cajal bands, which contain
substantial microtubule-based transport as well as ribosomal
activity (Ushiki and Ide, 1987; Sherman and Brophy, 2005). The
membrane appositions have tight morphology and are enriched
in periaxin (PRX)—themost abundant PNS non-compactmyelin
protein (de Monasterio-Schrader et al., 2012). Cajal bands
and the membrane appositions are important in regulating
myelin stability. These structures can be disturbed in human
demyelinating diseases, as well as in corresponding mouse
models (Sherman et al., 2001, 2012; Wu et al., 2012; Brennan
et al., 2015). Furthermore, PRX influences the myelin sheath
internode distance and thus influences nerve conduction velocity
(Court et al., 2004; Wu et al., 2012).
Two isoforms of PRX are generated through alternative
splicing (Dytrych et al., 1998). Disease mutations in PRX often
truncate the long C-terminal region of the larger L-PRX isoform
(Takashima et al., 2002). The molecular mechanism of disease
in these cases has remained enigmatic, as the best-characterized
protein interactions and functions of L-PRX so far lie very close
to the N terminus. These include the PDZ-like domain, which
mediates homo- and heterodimerization of PRX (Sherman et al.,
2001; Han and Kursula, 2014; Yang and Shi, 2015), and the
segment after it, which is known to bind dystrophin-related
protein 2 (DRP2) and link PRX to the dystroglycan complex
(Sherman et al., 2001). A conceivable additional mechanism
of PRX function and role in disease could involve specific
protein interaction sites at the C-terminal, isoform-specific end
of L-PRX.
We wanted to identify novel binding partners for the L-PRX
C-terminal region. The third cytoplasmic fibronectin-type III
(FNIII) domain of β4 integrin (β4-FNIII-3) was identified as a
high-affinity binder, and the complex was characterized using
biophysical and structural biology techniques. The observed
direct molecular interaction is likely to be important for the
function of PRX and β4 integrin in developing mature myelin,
and it provides a molecular basis for PRXmutations in CMT that
result in the expression of truncated L-PRX.
MATERIALS AND METHODS
Yeast Two-Hybrid Screening
Yeast two-hybrid screening was performed essentially as
previously described (Sherman et al., 2001). Briefly, a random-
primed rat sciatic nerve cDNA library in λACTII was screened
using the C-terminal region of rat L-PRX (residues 681–1383) in
the pAS2-1 vector (Clontech) as bait. Three independent clones
of β4 integrin each containing the third FNIII domain were
found. To identify the domain of PRX, which interacted with
β4 integrin, deletion constructs of PRX were made by PCR and
subcloned into pAS2-1. β-galactosidase activity was tested by
filter lift assays with one of the β4 integrin clones (62BpACTII).
GST Pulldown
The β4 integrin FNIII-3 domain (amino acids 1512–1593) cDNA
was amplified by PCR and subcloned into pGEXKG. As a
control, the adjacent fourth FNIII domain was cloned into
the same vector. The recombinant protein was expressed and
purified using a Glutathione-Sepharose 4B column as described
(Sherman et al., 2001). GST pulldowns were performed by
incubation of the GST fusion protein bound to Glutathione-
Sepharose with a sciatic nerve lysate, as previously described by
Sherman et al. (2001).
Immunoaffinity Chromatography
Immunoaffinity pulldowns were performed essentially as
described (Sherman et al., 2001). PRX and β4 integrin in
the pulldown fractions were identified by Western blot. PRX
antibodies have been described (Sherman and Brophy, 2018).
Antibodies against β4 integrin were raised in rabbits using a
peptide corresponding to amino acids 1756–1772, to which
an N-terminal cysteine was attached for coupling to keyhole
limpet hemocyanin (CTEPFLIDGLTLGTQRLE), as described
by Dytrych et al. (1998).
Immunofluorescence
Mice were perfused intravascularly with 4% paraformaldehyde
in 0.1 M sodium phosphate buffer (pH 7.3), and sciatic nerve
cryosections were prepared and immunostained as described
by Gillespie et al. (2000). Antibodies against PRX have been
described (Gillespie et al., 1994), and the monoclonal antibody
against β4 integrin was a generous gift from Dr. S.J. Kennel,
Biology Division, Oak Ridge National Laboratory.
Transfection and Coimmunoprecipitation
Full-length cDNA clones encoding rat β4 integrin and human
α6 integrin were subcloned into the expression vectors
pcDNA3.1 and pRC/CMV, respectively, and were generous gifts
from Dr M.L. Feltri, Hunter James Kelly Research Institute,
University of Buffalo and Dr Arnoud Sonnenberg, Netherlands
Cancer Institute. PRX cDNA in the expression vector pCB6 has
been described (Sherman and Brophy, 2000). PRX, β4 integrin,
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and α6 integrin were expressed in HEK293 cells. After
transfection, the proteins were immunoprecipitated as described
by Sherman et al. (2001).
Proteomics
Proteomics analyses were carried out exactly as described
by Sherman and Brophy (2018), comparing the PRX-bound
proteomes of PRX−/− mice carrying a transgene for either
wild-type PRX (PrxTg/PRX−/−) or PRX with a C-terminal
truncation mutation (mouse L-PRX truncated at residue
1016; ∆CPrxTg/PRX−/−) corresponding to human CMT4F
R1070X (Parman et al., 2004; Otagiri et al., 2006). Proteins
from mouse nerve lysates were crosslinked followed by
immunoprecipitation (IP) with a PRX antibody and then
subjected to mass spectrometry (MS) analyses. Normalized
abundance of β4 integrin was determined by MS using
Progenesis (Nonlinear Dynamics) as described by Sherman and
Brophy (2018).
Recombinant Protein Production
Synthetic genes encoding the rat L-PRX C-terminal region
(UniProt ID: Q63425, amino acids 1036–1383; PRX-C) and
rat β4-FNIII-3 (UniProt ID: Q64632, amino acids 1512–1602)
were ordered from DNA2.0 (Newark, CA, USA) in the
pJ401 bacterial expression vector. An additional sequence
encoding an N-terminal hexahistidine tag, a short linker,
and a tobacco etch virus (TEV) protease digestion site
(MHHHHHHSSGVDLGTENLYFQS) was included at the start
of the protein-coding insert.
PRX-C was expressed in E. coli BL21(DE3) using 0.4 mM
IPTG induction for 1.5 h in LB medium containing 100 µg/ml
ampicillin, at 37◦C. After expression, the cells were pelleted
by centrifugation and sonicated in Ni-NTA washing buffer
(40 mM HEPES, 400 mM NaCl, 6 M urea, 20 mM imidazole,
1 mM PMSF, pH 7.5) supplemented with protease inhibitors
(Roche). Purification was performed using Ni-NTA affinity
chromatography and standard procedures. Elution was done
with 32 mM HEPES, 320 mM NaCl, 4.8 M urea, 500 mM
imidazole, pH 7.5. The eluted fraction was dialyzed at 4◦C with
constant stirring against 40 mM HEPES, 400 mM NaCl, 1 mM
DTT, pH 7.5, before addition of recombinant TEV protease for
affinity tag removal (van den Berg et al., 2006). The digestion
was allowed to proceed overnight while dialyzing, which resulted
in cleaved PRX-C with an additional N-terminal Ser residue.
The protein was subjected to a second Ni-NTA step, in the
absence of urea. The unbound and wash fractions were combined
and concentrated, and sequential size exclusion chromatography
(SEC) on a HiLoad Superdex 200 pg 16/600 column (GE
Healthcare, Chicago, IL, USA) was used to separate the
cleaved protein from contaminants and degradation products.
Depending on downstream application, either 20 mM HEPES,
300 mM NaCl, 1% (v/v) glycerol, 0.5 mM TCEP, pH 7.5 (SEC
buffer) or 20 mMHEPES, 150 mMNaCl, pH 7.5 (HBS) was used
as running buffer.
β4-FNIII-3 was expressed in E. coli BL21(DE3) in LB or
TB medium containing 100 µg/ml ampicillin, with 0.4 mM
IPTG induction for 3 h at 37◦C. The cells were harvested as
above and resuspended in 40 mM HEPES, 400 mM NaCl,
20 mM imidazole, pH 7.5. After lysis by sonication, a Ni-NTA
chromatography was carried out essentially as described above,
omitting urea in all buffers. After Ni-NTA, the eluted protein
was directly subjected to SEC using a HiLoad Superdex 75 pg
16/60 column (GE Healthcare, Chicago, IL, USA) using either
HBS or SEC buffer.
Pulldown Experiment With Purified
Proteins
Purified recombinant β4-FNIII-3 and PRX-C were used in
pulldown experiments to confirm the direct interaction. PRX-C
with and without the His-tagged β4-FNIII-3 was mixed with
Ni-NTA agarose for 1 h at +4◦C, in binding buffer (20 mM
HEPES, 150 mM NaCl, 20 mM imidazole, pH 7.5). The matrix
was collected by centrifugation at 150 g for 5 min at +4◦C. Three
washes with binding buffer were carried out, and proteins were
eluted with 20 mM HEPES, 150 mM NaCl, 500 mM imidazole,
pH 7.5. All fractions were analyzed with SDS-PAGE.
In addition, a partially degraded PRX-C sample was employed
to identify fragments that do and do not bind β4-FNIII-3.
The pulldown experiment was carried out exactly as above.
Bands were excised from the gel and processed for tryptic
peptide mapping.
Synchrotron Radiation Circular Dichroism
(SRCD) Spectroscopy
SRCD data were collected from 0.15 to 0.6 mg/ml protein
samples in 20 mM Na-phosphate, 150 mM NaF, pH 7.5 on
the AU-CD beamline at the ASTRID2 synchrotron (ISA,
Aarhus, Denmark). Closed circular cells with a pathlength
of 100 µm (Suprasil, Hellma Analytics) were used for the
measurements. Spectra were recorded from 170 to 280 nm at
20◦C. Temperature scans were performed from 10 to 90◦C in
5◦C intervals, with 5 min incubation per time point, prior to
spectral acquisition.
Buffer spectra were subtracted from the protein samples,
and CD units were converted to ∆ε (M−1 cm−1), using
rPRX-C concentration determined using refractometry and/or
rFNIII-3 concentration determined using absorbance at 280 nm.
Deconvolution was performed using DichroWeb (Whitmore and
Wallace, 2004) with the CDSSTR algorithm (Johnson, 1999) and
SP175 reference set (Lees et al., 2006) or using BeStSel (Micsonai
et al., 2018). Secondary structure prediction was performed using
JPred (Drozdetskiy et al., 2015).
Small-Angle X-Ray Scattering (SAXS)
Synchrotron SEC-SAXS data for PRX-C, β4-FNIII-3, and their
complex were collected on the B21 beamline at Diamond Light
Source (Didcot, UK) using an online size exclusion setup.
The chromatography was performed using an Agilent 1200-
series HPLC system and a Superdex 200 increase 3.2/300GL
(GE Healthcare, Chicago, IL, USA) column with 20 mM Tris-
HCl, 150 mM NaCl, pH 7.4 as mobile phase at an isocratic
flow of 0.04 ml/min. Injections (45 µl) of 6.5–9.8 mg/ml
total protein were performed for PRX-C, β4-FNIII-3, and their
equimolar complex (145 µM each). Scattering was directly
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recorded from the eluted proteins at 6 s exposure per frame,
591 frames per run. The frames containing a stable Rg within
an eluted I0 peak were selected and combined using ScÅtter1.
Data were processed and analyzed using the ATSAS package
(Petoukhov et al., 2012). GNOM was used to calculate distance
distribution functions (Svergun, 1992), and ab initio modeling
was performed using GASBOR (Svergun et al., 2001). Multiphase
modeling of protein complex data was performed using MONSA
(Svergun, 1999) rigid body refinement with SASREF (Petoukhov
and Svergun, 2005), and ensemble optimization analysis with
EOM (Bernadó et al., 2007); see Supplementary Table S1 for
further details.
For intrinsically disordered proteins (IDPs), more accurate
values of Rg can be obtained from SAXS data using the Debye
formalism. Briefly, by plotting [I(s)]−1 vs. s2.206, in the range
(s Rg)2 < 3, one can use much more data than in a regular
Guinier plot. Here, a linear fit of the plot is used to obtain
Rg = (a/0.359b)0.453; a = slope, b = y intercept (Calmettes et al.,
1994). Theoretical values for Rg and Dmax for a random chain
can be calculated from sequence length as follows: Rg = R0Nv;
R0 = 1.98 Å, N = number of residues, v = 0.602 (Fitzkee and Rose,
2004) for denatured proteins; R0 = 2.54 Å, v = 0.522 (Bernadó and
Blackledge, 2009) for IDPs. Average end-to-end distance can be
estimated as<L2> = L0N; L0 = 81.8 Å (Fitzkee and Rose, 2004).
Mass Spectrometry and Covalent
Crosslinking
The molecular weight of PRX-C and β4-FNIII-3 was verified
by MS. In short, the undigested masses were determined
with ultra-performance liquid chromatography (UPLC)-coupled
electrospray ionization (ESI) time-of-flight MS in positive ion
mode, using a Waters Acquity UPLC-coupled Synapt G2 mass
analyzer with a Z-Spray ESI source.
Protein crosslinking was carried out to conjugate surface-
exposed carboxylate sidechains with lysines with a zero-length
crosslinker. All crosslinking reactions were carried out at 40 µM
final protein concentration in 100 mM bis-tris methane, 150 mM
NaCl, 4 mM 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide,
20 mM N-hydroxysuccinimide, pH 6.5. The activation step was
allowed to proceed for 15 min at ambient temperature, followed
by quenching the reactions through adding 2-mercaptoethanol to
20mM. After addition of the second protein in selected reactions,
incubation was continued for another 3 h at ambient temperature
and stopped by adding ethanolamine to 10 mM. The reactions
were analyzed using SDS-PAGE.
The crosslinked proteins were identified usingmatrix-assisted
laser desorption/ionization time-of-flight (MALDI-TOF) MS.
From stained SDS-PAGE gels, gel bands were cut, staining
removed by sequential washing with 50 mM NH4HCO3 in
40% acetonitrile (ACN). Proteins were subjected to in-gel Cys
reduction using 20 mM DTT and subsequent alkylation using
40 mM α-iodoacetamide. After this, all proteins were in-gel
digested [20 ng of trypsin (Sigma-Aldrich) per gel piece],
followed by peptide extraction from gel pieces using 30%
ACN/0.1% trifluoroacetic acid (TFA), and transfer to a Bruker
1http://www.bioisis.net/tutorial
anchor plate. 800 µg/ml α-cyano-4-hydroxy cinnamic acid in
85% ACN/0.1% TFA with 1 mMNH4H2PO4 was used as matrix.
Peptide mass spectra and MS/MS spectra were measured with
a Bruker Ultra fleXtreme MALDI-TOF mass spectrometer and
compared to theoretical spectra generated using the known
protein sequences.
Multi-Angle Static and Quasielastic Light
Scattering
SEC-MALS and quasielastic light scattering (QELS) data were
collected to determine the monodispersity, hydrodynamic
radius, and molecular weight of PRX-C, β4-FNIII-3, and their
equimolar complex (145 µM each). The chromatography was
performed using an Agilent 1200-series HPLC system and a
Superdex 200 increase 3.2/300GL (GE Healthcare, Chicago,
IL, USA) column with 20 mM Tris, 150 mM NaCl, pH
7.4 as a mobile phase. Protein samples of 160–250 µg were
injected into the column at an isocratic flow of 0.04 ml/min,
and light scattering was recorded using a Wyatt miniDAWN
HELEOS-II instrument with 18 detectors and a QELS module
at ambient temperature. The refractive index was measured
using a Wyatt Optilab T-rEX refractometer and used as the
concentration source. All data were analyzed using the ASTRA
software (Wyatt).
Protein Crystallography
β4-FNIII-3 was crystallized using sitting-drop vapor diffusion
in drops consisting of 150 nl protein solution (12.7 mg/ml in
SEC buffer) mixed with 150 nl of reservoir solution. Initially,
crystals were formed in a wide variety of PEG-based conditions
in PACT Premier and JCSG+ (Molecular Dimensions) crystal
screens. Optimized crystals used for diffraction data collection
were grown at 20◦C in conditions containing 16%–22% (w/v)
PEG 3350 and 180–240 mMNH4NO3.
Prior to diffraction data collection, the crystals were
cryoprotected briefly by adding 1.5 µl of cryoprotectant solution
directly into the sitting dropmix. The cryoprotectant consisted of
75% (v/v) well reservoir and 25% (v/v) PEG 400. After soaking in
cryoprotectant, crystals were mounted in loops and snap-frozen
in liquid N2.
X-ray diffraction data were collected at 100 K on the
P13 beamline, EMBL/DESY, Hamburg, Germany (Cianci et al.,
2017) and the ID30A-1 beamline at ESRF (Grenoble, France;
Bowler et al., 2015; Svensson et al., 2015). Data were processed
using XDS (Kabsch, 2010). Phasing was performed with
molecular replacement using the human β4-FNIII-3 structure
(PDB ID 4wtw; Alonso-García et al., 2015) as the search
model in Phaser (McCoy et al., 2007). The structure was
refined in phenix.refine (Afonine et al., 2012), and model
building was done in Coot (Emsley et al., 2010). The low
solvent content of 36% (including ordered water) leads to a
higher-than-average difference between Rwork and Rfree during
structure refinement.
The structure was validated and analyzed using DSSP (Kabsch
and Sander, 1983), MolProbity (Davis et al., 2004), PyMOL,
PDB2PQR (Dolinsky et al., 2004), APBS (Jurrus et al., 2018), and
UCSF Chimera (Pettersen et al., 2004). The crystal structure was
Frontiers in Molecular Neuroscience | www.frontiersin.org 4 April 2019 | Volume 12 | Article 84
Raasakka et al. L-PRX Binds β4 Integrin
subjected to atomistic molecular dynamics simulations for 550 ns
in YASARA (Krieger and Vriend, 2015), essentially as described
by Ponna et al. (2017).
Isothermal Titration Calorimetry (ITC)
PRX-C and β4-FNIII-3 were dialyzed into HBS overnight to
ensure matching buffer. The proteins were passed through a
0.22-µm filter, and concentrations were checked. Isothermal
titration calorimetry (ITC) was performed at 25◦C using a
Malvern MicroCal iTC200 calorimeter with reference power set
to 5µcal/s. 680µM β4-FNIII-3 was titrated into 350µl of 68µM
PRX-C under constant stirring. A total of 38 1-µl injections
were performed, with a 240-s waiting period between injections.
Data were analyzed using Origin. The titration experiment was
repeated twice with two separate protein batches and nearly
identical values were obtained in each case.
Four different peptides from PRX-C predicted to represent
a putative binding site were ordered from Genscript with
N-terminal acetylation and C-terminal amidation, and they
were similarly used to follow binding to β4-FNIII-3 with ITC.
The experiment was done at 25◦C with 2-µl injections with
150-s intervals. The cell contained 100 µM His-β4-FNIII-3
and the syringe 1 mM peptide. The peptide sequences were
ASFGEAGPEIAAPSAEGTVG (peptide 1; residues 1091–1110),
RIQVPQVMLELPGTQVAGGDLL (peptide 2; residues
1112–1133), GEGIFKMPTVTVPQLELDVGLGHEAQ (peptide
3, residues 1135–1160), and SGRRGRVRVRLPRVGLASPSK
(peptide 4; residues 1290–1310).
Thermal Stability Assays
Thermal stability experiments were performed for 0.25–2 mg/ml
β4-FNIII-3 and a 20 µM equimolar complex of PRX-C and
β4-FNIII-3 in SEC buffer using a label-free fluorescence-based
approach (nanoDSF). The instrument used was a NanoTemper
Prometheus NT.48 nanoDSF with a backscattering option to
detect aggregation onset. Each 10-µl sample was loaded inside
a glass capillary, and a constantly monitored scan from 20 to
95◦C using a 2◦C/min ramp rate was performed. Fluorescence
at emission wavelengths 330 nm and 350 nm (F330 and F350,
respectively) was monitored, and a single transition event was
observed in the fluorescence ratio (F350/F330) in all samples.
Melting temperature midpoint (Tm) values were extracted from
the first derivative peak maximum.
RESULTS
Identification of the Cytoplasmic Domain
of β4 Integrin as a Potential Periaxin Ligand
In order to identify putative protein ligands for the C-terminal
segment of L-PRX, which is missing in the presence of the
CMT4F R1070X mutation (Otagiri et al., 2006; Sherman and
Brophy, 2018), we carried out a yeast 2-hybrid screen of a
rat sciatic nerve cDNA library with the C-terminal segment,
missing upon the R1070X mutation, as bait. As a result, we
obtained three separate clones containing the β4-FNIII-3 domain
(Figure 1A). One of these (clone 62B) was further used in
confirmatory experiments.
The interaction was confirmed and the binding site coarsely
mapped by using different domains of L-PRX in the screen, with
the obtained β4 integrin construct 62B as bait (Figure 1B). The
results indicate that the last ∼350 residues, containing the acidic
region of L-PRX, are crucial for the interaction in this system.
Interestingly, both PRX(996–1165) and PRX(1168–1383) gave
negative results, suggesting that the binding site may be located
close to the point separating these two constructs, or that the site
might be a combination of more than one PRX segment required
to come together for high-affinity binding.
Evidence for β4 Integrin-PRX Interaction in
Tissues and Cells
As the next step, GST pulldowns from sciatic nerve lysates
were carried out using a GST-β4-FNIII-3 construct. Western
blotting identified L-PRX in the fraction bound to the GST
fusion protein, but not GST alone (Figure 1C). DRP2 was
also identified in the fraction pulled down by GST-β4-FNIII-3,
while GST-β4-FNIII-4 was unable to pull down PRX or DRP2
(Supplementary Figure S1). Immunoaffinity pulldowns were
further carried out using an anti-PRX antibody, and an analysis
of the fractions showed copurification of L-PRX and β4 integrin
(Figure 1D) when SDS—breaking up protein complexes—was
not used during extraction.
The putative interaction between L-PRX and β4 integrin
was further studied using co-IP from cultured HEK293 cells
overexpressing both proteins. After IP with either β4 integrin
or PRX antibodies, both proteins were observed in the eluted
fraction, showing they are present in the same complex
(Figure 1E).
To observe the localization of PRX and β4 integrin in
myelinating glial cells, immunofluorescence staining of mouse
sciatic nerves was carried out. The result confirms earlier studies
(Einheber et al., 1993; Feltri et al., 1994; Scherer et al., 1995),
in that both PRX and β4 integrin are localized at the outermost
membrane layer of myelin (Figure 1F).
Changes in the L-PRX Interactome in a
Mouse Model of CMT4F
The mouse model for CMT4F (Sherman and Brophy, 2018),
∆CPrxTg/Prx−/−, carries a truncating mutation mimicking
human L-PRX with the R1070X mutation. The phenotype of
this mouse mutant involves the loss of abaxonal membrane
appositions and shortening of internodal lengths (Sherman
and Brophy, 2018), while the Prx−/− phenotype presents
initial hypermyelination with progressing demyelination and
neuropathic pain behavior; for a full description, see Gillespie
et al. (2000). We carried out proteomics experiments to follow
the expression level of possible PRX ligand proteins in the
∆CPrxTg/Prx−/− model. PRX was immunoprecipitated from
mouse nerves after crosslinking, and the bound proteins were
analyzed and compared between the ∆CPrxTg/Prx−/− and
PrxTg/Prx−/− samples. The levels of DRP2 were decreased in the
PRX interactome of∆CPrxTg/Prx−/−mutant animals (Sherman
and Brophy, 2018). In addition, a several-fold drop in the level of
β4 integrin could here be observed in themutant compared to the
PrxTg/Prx−/− animals based on data from the same experiment
Frontiers in Molecular Neuroscience | www.frontiersin.org 5 April 2019 | Volume 12 | Article 84
Raasakka et al. L-PRX Binds β4 Integrin
FIGURE 1 | Identification of an interaction between periaxin and β4 integrin. (A) Top: structure of full-length L-PRX and the bait used in a yeast two-hybrid screen
using the C terminus of L-PRX (aa 681–1383) fused to the GAL4 DNA-binding domain. Bottom: structure of the intracellular domain of β4 integrin and one (62B) of
the three clones recovered from the screen, all of which included the third FNIII domain of β4 integrin. (B) Identification of the region of PRX, which binds to
β4 integrin. The strength of interaction between the 62B clone and a series of PRX constructs in a yeast two-hybrid β-galactosidase assay was assessed
semiquantitatively by the time taken for colonies to turn blue (+++, 30 min; ++, 30–60 min; +, 60–180 min). (C) Interaction of β4-FNIII-3 with PRX in vitro. GST or a
GST-β4-FNIII-3 fusion protein were incubated with a sciatic nerve lysate in vitro and any bound L-PRX was detected by Western blotting (IB) using a PRX antibody
after SDS-PAGE. The input lane confirms the presence of PRX in the lysate. Coomassie blue staining shows that equivalent amounts of GST and the GST fusion
proteins were used. (D) Immunoaffinity copurification of β4 integrin and PRX. Detergent extracts of mouse sciatic nerve in the non-ionic detergent Igepal were
incubated with beads, to which affinity-purified sheep anti-PRX antibodies had been covalently coupled. After extensive washing, bound proteins were eluted and
analyzed by SDS-PAGE and Western blotting. The SDS control lane contains proteins that bound to the beads after first solubilizing the nerves in SDS to disrupt
protein-protein interactions, followed by dilution of the SDS with Triton X-100. (E) Coimmunoprecipitation of β4 integrin and PRX from transfected HEK293 cells. PRX
and β4 integrin were detected by Western blot (IB) after immunoprecipitation (IP) with β4 integrin antibodies when β4 integrin, α6 integrin, and PRX were
coexpressed. Preimmune serum (PI) did not precipitate either protein. Reciprocally, β4 integrin and PRX were detected by Western blot after IP with anti-PRX
antibodies, when β4 integrin, α6 integrin, and PRX were coexpressed. (F) Immunohistochemistry. Both PRX (green) and β4 integrin (red) localize at the abaxonal
membrane in mature myelin. (G) Quantification of β4 integrin from the IP of crosslinked sciatic nerves from the full-length PRX transgenic mouse on a PRX null
background (n = 3) vs. C-terminally truncated PRX transgene on a PRX null background (n = 3).
(Figure 1G). The result provides strong evidence for a functional
protein complex involving L-PRX and β4 integrin in mouse
peripheral nerve myelin in vivo.
Complex of Purified Recombinant
β4 Integrin and PRX
The above experiments provided evidence for a direct interaction
between L-PRX and β4 integrin in myelinating Schwann cells.
We conducted a biophysical characterization of the interaction
using recombinant PRX-C and β4-FNIII-3.
Pulldown experiments with the purified components
confirmed the direct molecular interaction suggested by the data
above. His-tagged β4-FNIII-3 pulled down PRX-C (Figure 2A).
Pulldown of a partially degraded PRX-C sample showed that
essentially all PRX fragments on the SDS-PAGE gel were pulled
down by β4-FNIII-3 (Figure 2B). MS analysis indicated that the
shortest fragments were missing the very C-terminal regions,
while the acidic domain was well-covered in all fragments (data
not shown), suggesting that the N-terminal half of the PRX-C
construct contained the binding site.
SEC-MALS and QELS experiments verified the interaction
in vitro, whereby the observed complex mass fit to a
1-to-1 complex, with an increased hydrodynamic radius
(Rh) compared to the individual interaction partners alone
(Figure 2C, Table 1). Rh of the complex was only slightly higher
than that for PRX-C, indicating that the complex remained in
an extended overall conformation; this is also reflected in the
very small change in SEC elution volume. As β4-FNIII-3 is small
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FIGURE 2 | Direct molecular interaction assays using purified recombinant proteins. (A) Pulldown with pure recombinant proteins on a Ni-NTA affinity matrix. Top,
PRX-C and His-tagged β4-FNIII-3; middle, PRX-C alone; bottom; partially degraded PRX-C and His-tagged β4-FNIII-3. Samples: 1, input sample; 2, unbound
fraction; 3–5, washes; 6, elution. PRX-C is indicated in red and β4-FNIII-3 in blue. Sizes of molecular weight markers are indicated on the left (kDa). (B) Sequence of
the PRX-C construct, indicating the presence of acidic and basic repeats. The underlined segment (the acidic domain) can be detected in all the PRX-C bands in the
bottom panel of (A). (C) Size exclusion chromatography (SEC)-MALS analysis shows molecular mass expected for a 1:1 complex. PRX-C, red; β4-FNIII-3, blue;
complex, black. (D) Isothermal titration calorimetry (ITC) titration of the complex indicates 1:1 stoichimetry. ∆H = 6.2 ± 0.06 kcal/mol, ∆S = 5.8 cal/mol◦. (E)
Covalent crosslinking. The complex is only visible when both proteins have been activated (Lane 1). The magenta arrowhead indicates the 1:1 complex. PRX-C is
indicated in red and β4-FNIII-3 in blue. Samples: 1, both proteins activated; 2, PRX-C activated; 3, PRX-C activated, β4-FNIII-3 added; 4, no activation; 5, no
activation, PRX-C added; 6, no activation, β4-FNIII-3 added; 7, β4-FNIII-3 activated; 8, β4-FNIII-3 activated, PRX-C added.
and tightly folded, this implicates that the PRX-C segment does
not become compact upon complex formation, which would be
indicated by a decreased Rh.
A dissociation constant of 1.7 ± 0.1 µM was obtained for the
protein-protein complex using ITC, with a binding stoichiometry
of ∼1 (Figure 2D), being in good corroboration with the light
scattering data above. Hence, the C-terminal region of L-PRX
and β4-FNIII-3 bind each other with a low micromolar affinity,
in a complex tight enough to survive e.g., separation by SEC. The
stoichiometry suggests that the interaction site is either distinct
from the repeat sequences in L-PRX, or that maximally one
β4 integrin molecule can bind to PRX-C even if the binding site
would involve the repeats. For more insight, ITC was repeated
with selected peptides representing different features of the
PRX-C sequence, but no binding to these linear peptide motifs
was observed (Supplementary Figure S2).
Covalent crosslinking and MS were used in an attempt
to map the binding site in more detail. An additional band
containing both proteins was apparent on SDS-PAGE after
crosslinking (Figure 2E). MS analysis of tryptic peptides from
this band confirmed the presence of both PRX-C and β4-
FNIII-3, but no conclusions could again be drawn on the exact
binding site.
Thermal stability of the proteins was studied using label-free
differential scanning fluorimetry (nanoDSF), whereby the signal
came from the folded β4-FNIII-3 domain. β4-FNIII-3 has the
same melting point (+70◦C) in the presence and absence of
PRX-C (Table 2), suggesting no large structural changes are
induced by PRX-C binding.
Taken together, the above experiments have shown a direct
protein-protein interaction between β4-FNIII-3 and PRX-C.
However, the detailed binding mode and binding site(s) remain
to be identified.
Structural Insights into the Protein-Protein
Complex
While PRX-C is predicted to contain segments of β strand,
the purified protein is essentially unfolded, as shown by SRCD
spectroscopy (Figure 3A, Table 2). The β strand predictions
coincide with repeats in the sequence (Figure 3B), and they
could be of functional relevance in ligand protein binding and
induction of secondary structures in PRX-C.
SRCDwas used to shed light on possible changes in secondary
structure content accompanying complex formation. The spectra
clearly show that the overall secondary structure content remains
identical in the complex, compared to the two proteins in
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isolation (Figure 3A). Together with the SAXS data (see below),
SRCD shows that upon β4-FNIII-3 binding, the PRX C-terminal
segment does not obtain large amounts of folded structure. Heat
denaturation experiments by SRCD confirmed the same melting
point for β4-FNIII-3 in the presence and absence of PRX-C
(Table 2).
To aid in structural modeling and understanding the
interactions in the complex, we solved the high-resolution crystal
structure of the rat β4-FNIII-3 domain (Figure 4, Table 3). The
structure is similar to the human β4-FNIII-3 domain (Alonso-
García et al., 2015), consisting of a β sandwich made of seven β
strands. In two of the four monomers in the asymmetric unit,
the His tag could be partially seen in electron density, being in
different conformations (Figure 4).
Purified PRX-C was subjected to SAXS experiments to
gain more insight into its flexibility, molecular dimensions,
and conformational ensembles. These experiments indicate that
PRX-C behaves much like a random polymer chain and is highly
extended (Figure 5, Table 1).
While SAXS indicated a highly disordered nature for PRX-C
alone, we wanted to observe, whether it becomes more ordered
in the complex with β4-FNIII-3. The β4-FNIII-3 crystal structure
was used to model the solution structure of the complex, which
cannot be crystallized due to the flexible nature of PRX and the
fact that the exact binding site remains unknown. SAXS analysis
of the protein complex, based on a SEC-SAXS experiment, shows
that PRX-C remains elongated, and extra density corresponding
to the size of a β4-FNIII-3 molecule appears close to one end of
the complex (Figures 5D,E). This is in line with the results from
SEC-MALS (see above).
The structure of β4-FNIII-3 can be used to predict the binding
site for PRX. A surface analysis of the domain crystal structure
indicates an elongated hydrophobic groove lined by β strands
4 and 5 (Figures 4, 6A), which could accommodate a linearmotif,
possibly in a β conformation; this would extend the smaller β
sheet from 3 to 4 β strands. MD simulations of the structure
further show that this region is the most mobile segment of β4-
FNIII-3, and the cavity can open even more (Figures 6B–D).
Furthermore, although the FNIII-3 and -4 domains of β4 integrin
are rather homologous, sequence conservation in the possible
binding site is very low—in line with the observation that FNIII-4
does not bind to PRX (Supplementary Figure S1). More detailed
structural data can be obtained, once the exact binding site(s)
have been identified.
DISCUSSION
At the cellular level, myelin formation involves a substantial
amount of lipid and protein synthesis and their subsequent
assembly into a multilayered, tightly packed proteolipid
multilayer. The molecular interactions involved in this process
can be roughly divided into those involved in the formation of
the compact myelin compartment, and into those relevant for
non-compact myelin. This division does not imply that a single
protein cannot take part in both aspects; for example, myelin
basic protein functions both in membrane packing and in the
regulation of cytoplasmic channels (Snaidero et al., 2017).
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TABLE 2 | Folding and thermal stability of PRX-C and β4-FNIII-3.
SRCD deconvolution* Secondary structure prediction∗∗ Tm, ◦C
% helix % strand % other % helix % strand % other SRCD nanoDSF
PRX-C 3 38 58 0 7.7 92.3 - -
3 31 66
β4-FNIII-3 1 45 51 0 (0) 37.2 (34.5) 62.8 (65.5) 59.5 ± 0.6 69.8 ± 0.1
2 50 49
Complex 2 39 56 0 14.9 85.1 58.8 ± 0.7 70.3 ± 0.1
3 35 61
*Deconvolved using DichroWeb (values above), or with BeStSel (values below). ∗∗ Predicted from primary structures using JPred. Values in brackets were extracted from the crystal
structure using DSSP. The complex values were calculated from the JPred predictions, assuming a 1:1 complex.
FIGURE 3 | L-PRX remains disordered in the complex. (A) Synchrotron radiation circular dichroism (SRCD) spectroscopy. PRX-C, red; β4-FNIII-3, blue; complex,
black; sum of individual protein spectra, magenta. (B) Secondary structure predictions of the PRX-C acidic region, aligned from selected species.
FIGURE 4 | Crystal structure of rat β4-FNIII-3 (stereo view). Two of the
four individual chains in the asymmetric unit are shown. The chain is colored
from the N (blue) to the C (red) terminus. The His-tag is partially resolved at
the N terminus, and takes different conformations in different monomers.
Secondary structure elements are labeled.
Both PRX and β4 integrin play important roles in peripheral
nerve myelination (Gillespie et al., 2000; Court et al., 2004;
Nodari et al., 2008). Recently, it was suggested that PRX
may be a ligand for β4 integrin (Poitelon et al., 2018),
and the interaction has been mentioned before (Wu et al.,
2012), but not studied in detail. We set out to confirm this
putative direct molecular interaction and to obtain 3D structural
data on the protein-protein complex formed by PRX and
β4 integrin.
L-PRX Binds β4 Integrin Directly With High
Affinity
Integrins are involved in myelination by both oligodendrocytes
(CNS) and Schwann cells (PNS). In Schwann cells, the
two main isoforms of integrin are α6β1 and α6β4. While
α6β1 is expressed in the early stages of myelination and
is crucial for the radial sorting of axons (Feltri et al.,
2002; Poitelon et al., 2016), α6β4 is predominant in the
late stages and mature myelin (Einheber et al., 1993; Feltri
et al., 1994). This indicates a developmental switch during
myelination and suggests that β4 integrin is important for
myelin maturation and maintenance. The levels of the Schwann
cell laminin receptors integrin α6β1, α6β4 and dystroglycan
are all regulated by the transcriptional co-activators Yap
and Taz (Poitelon et al., 2016). The two basal lamina
receptors of mature myelin, α6β4 integrin and dystroglycan,
known to be together responsible for myelin stability (Nodari
et al., 2008), are according to our results bound to the
same scaffold protein, L-PRX, at the Schwann cell abaxonal
plasma membrane.
We have shown here with a collection of methods that
L-PRX binds, through its C-terminal region, directly to β4-
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TABLE 3 | Crystallographic data collection and refinement statistics.
Data collection statistics
Beamline ID30A-1 (ESRF)
Space group P212121
Unit cell a, b, c (Å) 51.22, 52.84, 144.53
Wavelength (Å) 0.966
Resolution (Å) 50–1.60 (1.64–1.60)
Unique reflections 51757 (3746)
Multiplicity 3.3 (3.3)
Completeness (%) 98.3 (98.6)
Rmerge (%) 6.1 (239.2)
Rmeas (%) 7.3 (283.9)
<I / σ(I) > 8.8 (0.6)
CC 1
2
(%) 99.8 (16.6)
Wilson B (Å2) 39.2
Refinement statistics
Rcryst (%) 19.0
Rfree (%) 23.9
RMSD bond length (Å) 0.013
RMSD bond angle (◦) 1.1
Mean B value (Å2) 49.7
Ramachandran plot
Res. in favored regions (%) 95.9
Outlier residues (%) 0.8
MolProbity score/percentile 2.05/44th
PDB entry 6HYF
Values in parentheses correspond to the highest-resolution shell.
FNIII-3 with high affinity. Considering the presence of both
proteins in a large protein scaffold at the Schwann cell outermost
membrane, it is likely that the affinity is even higher when
full-length proteins interact and avidity is increased by e.g.,
protein clustering and oligomerization. PRX could function
as a ruler between integrins and dystroglycans on the cell
surface; on the other hand, changes in the clustering of
these molecules, e.g., through changes in the basal lamina,
might affect the conformation of PRX as well as its cytosolic
interactions. The importance of these interactions could lie in
defining the boundaries of the appositions and Cajal bands
at the abaxonal membrane, as DRP2 is restricted to the
appositions and integrin signaling occurs at Cajal bands (Salzer,
2015). It is possible that PRX binds to DRP2 in appositions
and β4 integrin at Cajal bands separately. Clearly, more
detailed in vivo experiments will be required to resolve these
important details.
The exact binding site of β4 integrin on L-PRX remains to be
determined. Despite a number of approaches, we were not able
to highlight a short segment responsible for binding. Despite the
presence of two kinds of repeats in the PRX-C sequence, neither
of these was enough to bind alone. Mapping of the binding
site through the yeast two-hybrid experiments also proved to be
inconclusive; while the full PRX-C region showed strong binding,
cutting the region in two (constructs 996–1165 and 1168–1383)
resulted in the loss of detectable interaction. It is likely that the
binding to β4 integrin involves more than one segment of PRX-
C—possibly a combination of an acidic and a basic repeat. This
will clearly be a subject of more detailed structural studies in
the future.
Similarly to the reduction seen here in the PRX
interactome of β4 integrin in mice with truncated
L-PRX, corresponding to human CMT4F mutation
R1070X (Sherman and Brophy, 2018), a recent study
(Poitelon et al., 2018) showed the loss of PRX from the
β4 integrin interactome in mice with β4 integrin deficiency.
It was thereby suggested that PRX might link β4 integrin
functionally to PMP22 (Poitelon et al., 2018), but a direct
or indirect interaction between PRX and PMP22 remains to
be detected.
L-PRX Is Intrinsically Disordered
The C-terminal segment of L-PRX is highly flexible and
intrinsically disordered, as shown by structure predictions, SRCD
spectroscopy, and SAXS. The potential of intrinsically disordered
regions in mediating specific protein interactions has been
recently highlighted in number of studies (Barbar and Nyarko,
2015; Jie et al., 2015; Myllykoski et al., 2018). Such complexes
involve usually the recognition of short linear motifs by a folded
binding partner. In the current case, PRX-C remains highly
flexible even upon β4 integrin binding. Considering the ratio
Rg/Rh, the complex, having a lower ratio, is likely to be somewhat
less flexible than PRX-C alone. Molecular flexibility may be
important for the supramolecular organization of the protein
scaffold at the outermost layer of PNSmyelin, whereby PRX plays
a central role.
Intriguingly, many of the myelin-specific proteins have
a high degree of intrinsic disorder, as well as specific
interactions, which makes myelin an interesting case for
studying biomedically relevant intrinsically disordered proteins
and their interactions. A well-studied example is the myelin
basic protein, which is intrinsically disordered in solution, but
partially folds upon membrane binding (Harauz et al., 2009;
Raasakka et al., 2017). MOBP and the cytoplasmic domain
of P0 are predicted to be disordered (Han et al., 2013), and
the latter is intrinsically disordered in solution (Luo et al.,
2007; Raasakka et al., 2019a). The cytoplasmic domain of
the large myelin-associated glycoprotein is an intrinsically
disordered protein but forms a specific heterotetramer
upon dynein light chain binding, which is likely to help
in dimerization and affect binding to the axonal surface
(Myllykoski et al., 2018).
In addition to the C-terminal segment studied here, most
of the L-PRX-specific region is predicted to be intrinsically
disordered. Hence, a monomer of L-PRX, assumed to be mainly
in random coil conformation, could reach a length of >30 nm
(Fitzkee and Rose, 2004), which would be nearly doubled in
the case of an L-PRX dimer formed through domain swapping
at the N-terminal PDZ-like domain (Han and Kursula, 2014).
PRX may thus be able to act as a molecular ruler and mediate
protein interactions across partners distributed widely across the
Schwann cell abaxonal membrane. The distance between bound
DRP2 and β4 integrin can be estimated to be up to ∼25–30 nm,
depending on the exact binding site and the conformation of
L-PRX between the binding sites. The flexibility of L-PRX should
allow it to stay bound to both protein complexes, even in the
case they rearrange on themembrane. Such interactionsmight be
possible, for example, at the edges between abaxonal membrane
appositions and Cajal bands.
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FIGURE 5 | Structure of the complex in solution. (A) Small-angle X-ray scattering (SAXS) scattering curve. PRX-C, red; β4-FNIII-3, blue; complex, black. (B)
Dimensionless Kratky plot. The black cross indicates the theoretical peak position for a folded, perfectly globular protein. (C) Distance distribution function. (D)
Multi-phase model from MONSA. PRX-C, pink; β4-FNIII-3, blue. (E) Rigid-body fit between a chain-like model of PRX-C (pink) and the integrin crystal structure (blue).
(F) EOM analysis for PRX-C. Dashed lines, theoretical distribution for a random coil; solid lines, the ensemble for PRX-C. Maximum dimension is shown in red and
radius of gyration in black. PRX-C is slightly more elongated than a random coil.
Insights From Structure of the Protein
Complex
The binding site for β4 integrin in L-PRX remains unknown,
although the mapping in this study suggests that the acidic
region of L-PRX is involved. A sequence alignment of this
region (Figure 3B) from different species shows that only a few
segments are highly conserved; it is conceivable that these regions
have functional relevance and they could form the binding
site. Further studies will be required to obtain higher-resolution
structural data to fully understand the binding interactions.
Typical modes of target protein binding by FNIII domains
include transient opening and domain swapping (Ohashi et al.,
2009). It is possible that some of the conserved segments in
L-PRX are involved in a domain-swapping rearrangement of β4-
FNIII-3. Such a mechanism would be compatible with the lack of
change in secondary structure content upon complex formation,
which we observed in SRCD experiments. High-resolution
structural studies should answer many of the currently open
questions, which will require the identification of the exact
binding site(s).
Considering the structures of both L-PRX and β4 integrin,
it is possible that additional binding surfaces are present in
both proteins. β4 integrin has four FNIII domains in its
cytoplasmic domain, and the C-terminal region of L-PRX is large
and flexible, containing repetitive sequences. The fourth FNIII
domain of β4 integrin does not bind to PRX-C (Supplementary
Figure S1), however, and it is important to recapitulate that the
stoichiometry of the interaction between PRX-C and β4-FNIII-
3 was observed here to be 1:1.
Relevance for Understanding
Demyelinating Disease
A number of proteins have been characterized as targets
for mutations in human hereditary neuropathies, whereby
the structure of the myelin sheath is compromised. Detailed
knowledge about protein interactions in myelin is required to
accurately understand the molecular bases of such diseases. One
such protein is PRX, which is expressed as two isoforms, S- and
L-PRX.While S-PRX consists of only a dimeric PDZ-like domain
and a short tail, L-PRX dimerizes through the N terminus
similarly to S-PRX (Han and Kursula, 2014), but has in total
∼1,400 residues. Little is known about the structure and function
of the long, repetitive L-PRX-specific segments. Expression of
S-PRX may result in PRX heterodimerization (Yang and Shi,
2015) and affect the regulation of the PRX-containing protein
scaffold, as S-PRX interacts with neither DRP2 nor β4 integrin.
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Most PRX mutations causing human hereditary neuropathy
introduce a premature stop codon into the sequence (Guilbot
et al., 2001; Tokunaga et al., 2012; Choi et al., 2015). In line
with this, patients with such mutations have PRX expressed, but
its size is smaller than in normal individuals (Parman et al.,
FIGURE 6 | Possible binding site for L-PRX. (A) Surface of the
β4-FNIII-3 crystal structure, colored by electrostatic potential. The predicted
binding site is shown by a green dashed line. (B) MD simulation indicates the
possible binding site is flexible (arrow) and may open up more. (C) RMSF
during the 550-ns simulation. (D) Comparison of the start (magenta) and end
(yellow/green) points of the simulation. The loop at the potential binding site
(arrow) is the most mobile region. The largest peak in the RMSF plot (panel C)
is colored green in the post-simulation structure.
2004; Kabzinska et al., 2006). These observations hint at the
possibility that an important function of L-PRX during myelin
formation and maintenance lies at its C-terminal region. This
is intriguing, given our observation that this region of L-PRX is
intrinsically disordered. Here, we have shown a tight interaction
between this C-terminal region and the third FNIII domain in the
β4 integrin cytoplasmic domain—in the case of PRX truncations,
such an interaction would be abolished. This would be expected
to cause large-scale disturbances in the PRX-related protein
scaffold reaching to the basal lamina and may translate to defects
inmyelinmaintenance, such as the loss of membrane appositions
in the ∆CPrxTg/Prx−/− mice (Sherman and Brophy, 2018).
Interactions with DRP2 are important for PRX function, but for
a stable myelin sheath, links between the Schwann cell cytoplasm
and the basal lamina through β4 integrin may be crucial. L-PRX,
hence, mediates a two-pronged interaction from the cytoplasmic
side through the Schwann cell plasma membrane to the basal
lamina (Figure 7) and might have a role in sequestering different
types of laminin receptors. How this relates to the formation and
stability of appositions and Cajal bands in vivo still remains to be
determined. The identification of β4 integrin as another L-PRX
ligand provides an important starting point for future studies.
Loss of O-glycosylation causes similar phenotypic effects as
L-PRX truncation in mouse models of CMT4F (Kim et al., 2016).
Several O-glycosylation sites in PRX were identified, and some of
them reside in the C-terminal region, which binds to β4 integrin.
It is possible that PTMs, including O-glycosylation, regulate PRX
interactions with β4 integrin in a dynamic manner.
Integrin β4 has been highlighted both as a biomarker for
Guillain-Barré syndrome (Sessa et al., 1997; Previtali et al.,
1998; Archelos et al., 1999), an autoimmune demyelinating
disease of peripheral nerves, and as a central molecule in the
entry of Mycobacterium leprae into Schwann cells, via the basal
lamina (Rambukkana et al., 1997). Leprosy is characterized by
peripheral nerve damage initiated by mycobacterial infection of
FIGURE 7 | Schematic view of the PRX-linked protein scaffold in peripheral nervous system (PNS) myelin. (A) Cross section of a myelinated peripheral axon,
showing compact myelin, the abaxonal membrane, Cajal bands, and appositions. While dystrophin-related protein 2 (DRP2) is restricted to the appositions, and PRX
is concentrated in them, β4 integrin is involved in signaling in the Cajal bands (Salzer, 2015). (B) A possible architecture for L-PRX-based protein scaffolds at the
Schwann cell abaxonal membrane. The position of the truncating R1070X mutation in L-PRX is indicated, and the β4 integrin binding site lies C-terminal to it,
although an exact binding site remains to be identified.
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the Schwann cells. It is currently not known, how L-PRX binding
to β4 integrin might modulate this process. Our data provide
starting points for such studies in the future.
CONCLUSION
The dimeric, highly elongated, flexible L-PRX is capable of
acting as a central protein scaffold within non-compact myelin,
linking integrins and dystroglycans together, thus bridging
together two major protein complexes linking Schwann cells
to the extracellular matrix. This could have high relevance in
ensuring the formation and necessary stability of membrane
appositions that drive the formation of Cajal bands. The PRX-
β4 integrin complex is likely to be important in both normal
myelination, myelin maintenance, as well as the pathophysiology
of neurodegenerative disease. Obviously, additional in vivo and
structural biology approaches will be required in the future to
fully corroborate our data and relate them tomyelin development
and the demyelinating phenotype in CMT4F.
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